跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNGLUCON TABLET 5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
SUNGLUCON TABLET 5 mg
Approved
THERAPEUTIC
SUNGLUCON TABLET 5 mg
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Jan 29, 1999
Approval ID
ed83c8831d91e4d7
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Type
Therapeutic
Approval Details
Approval Id
ed83c8831d91e4d7
Drug Name
SUNGLUCON TABLET 5 mg
Product Name
SUNGLUCON TABLET 5 mg
Approval Number
SIN10724P
Approval Date
1999-01-29
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
A10BB07
Atc Item Name
glipizide
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path
/organization/sunward-pharmaceutical-private-limited
Active Ingredients
GLIPIZIDE
5 mg
GLIPIZIDE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 29, 1999
Approval ID
ed83c8831d91e4d7
Type
Therapeutic
Back to HSA Approvals